Skip to main content
KALA
NASDAQ Life Sciences

KALA BIO Executes 1-for-50 Reverse Stock Split to Boost Share Price and Maintain Nasdaq Listing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.084
Mkt Cap
$77.241M
52W Low
$0.078
52W High
$20.6
52W Position info
8.3% above low
Off High info
100% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

KALA is trading near its 52-week low of $0.078 (8.3% above the low).

Summary

KALA BIO, Inc. has officially enacted a 1-for-50 reverse stock split, effective May 8, 2026, to consolidate its outstanding shares and increase its per-share trading price.


Key Events · Corporate Governance and Compliance · KALA

  • 1-for-50 Reverse Stock Split Enacted

    KALA BIO, Inc. filed a Certificate of Amendment to its Restated Certificate of Incorporation to effect a 1-for-50 reverse stock split of its common stock. This action was approved by stockholders on January 30, 2026, with the Board determining the 1-for-50 ratio.

  • Effective Date and Trading Impact

    The reverse stock split becomes effective at 4:05 p.m. (Delaware time) on May 8, 2026. Common Stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market on May 11, 2026, under the existing 'KALA' symbol.

  • Share Count Reduction

    The split will reduce the number of outstanding common shares from approximately 929.5 million to about 18.6 million. The number of authorized shares remains unchanged at 1.5 billion.

  • Fractional Shares and Nasdaq Compliance

    No fractional shares will be issued; stockholders entitled to fractional shares will receive a cash payment based on the May 7, 2026 closing price. This move is critical for the company to maintain its Nasdaq listing, especially given prior 'going concern' warnings.


Analysis · KALA · Life Sciences

KALA BIO's decision to implement a 1-for-50 reverse stock split is a critical move, likely aimed at increasing its per-share price to meet Nasdaq's minimum bid requirements. This action follows a recent 10-K filing that disclosed substantial doubt about the company's ability to continue as a going concern, making the reverse split a necessary step to avoid delisting and potentially enable future financing. While it does not change the company's fundamental valuation, reverse stock splits are generally viewed negatively by the market as they often signal financial distress and historically precede further stock price declines. Investors should monitor the post-split trading performance and any subsequent capital raising efforts.

How filings like this one have moved

In the 30 days to Oct 31, 2026, 48.4% of the 215 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.85%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, KALA was trading at $0.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $77.2M. The 52-week trading range was $0.08 to $20.60. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

KALA - Latest Insights

KALA
Sep 29, 2026, 7:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.474
Real-time Price: $0.1763 info
Change: -$0.2977 (-63%) info
Market Cap: $3.201M info
KALA
Sep 24, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.5288
Real-time Price: $0.1763 info
Change: -$0.3525 (-67%) info
Market Cap: $3.201M info
KALA
Sep 11, 2026, 4:56 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.590
Real-time Price: $0.1763 info
Change: -$0.4137 (-70%) info
Market Cap: $3.201M info
KALA
Sep 03, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.538
Real-time Price: $0.1763 info
Change: -$0.3617 (-67%) info
Market Cap: $3.201M info
KALA
Aug 28, 2026, 6:45 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.795
Real-time Price: $0.1763 info
Change: -$0.6187 (-78%) info
Market Cap: $3.201M info